DiaMedica Therapeutics Inc. (DMAC) earnings
Quarterly results of DiaMedica Therapeutics Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
DiaMedica Therapeutics Inc. is expected to report around November 11, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) DiaMedica Therapeutics Inc. reported revenue of - and a net loss of $10.1M.
Diluted earnings per share were -$0.19.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$10.1M | -$0.19 |
| Q1 FY2026 | - | - | -$10M | -$0.19 |
| Q4 FY2025 | - | - | -$8.7M | - |
| Q3 FY2025 | - | - | -$8.6M | -$0.17 |
| Q2 FY2025 | - | - | -$7.7M | -$0.18 |
| Q1 FY2025 | - | - | -$7.7M | -$0.18 |
| Q4 FY2024 | - | - | -$7.9M | - |
| Q3 FY2024 | - | - | -$6.3M | -$0.15 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly results 8-K
- Annual report 10-K
- Quarterly report 10-Q
- Quarterly results 8-K
When is DiaMedica Therapeutics Inc.'s next earnings date?
DiaMedica Therapeutics Inc. is expected to report around November 11, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Get an email when DMAC reports
Follow DMAC and we email you its next results the day they are filed, with the numbers explained.